323 related articles for article (PubMed ID: 10323594)
41. Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cells.
DeLapp N; Wu S; Belagaje R; Johnstone E; Little S; Shannon H; Bymaster F; Calligaro D; Mitch C; Whitesitt C; Ward J; Sheardown M; Fink-Jensen A; Jeppesen L; Thomsen C; Sauerberg P
Biochem Biophys Res Commun; 1998 Mar; 244(1):156-60. PubMed ID: 9514902
[TBL] [Abstract][Full Text] [Related]
42. Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer.
Gupta S; Singh RK; Nanda K; Chatterjee M; Tiwari A; Sundaram S; Gupta D; Chugh A; Dastidar S; Ray A
J Recept Signal Transduct Res; 2009; 29(2):100-6. PubMed ID: 19288301
[TBL] [Abstract][Full Text] [Related]
43. An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins.
Mistry R; Dowling MR; Challiss RA
Br J Pharmacol; 2005 Feb; 144(4):566-75. PubMed ID: 15655507
[TBL] [Abstract][Full Text] [Related]
44. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor.
Frucht H; Jensen RT; Dexter D; Yang WL; Xiao Y
Clin Cancer Res; 1999 Sep; 5(9):2532-9. PubMed ID: 10499630
[TBL] [Abstract][Full Text] [Related]
45. Rat dorsal root ganglia express m1-m4 muscarinic receptor proteins.
Bernardini N; Levey AI; Augusti-Tocco G
J Peripher Nerv Syst; 1999; 4(3-4):222-32. PubMed ID: 10642090
[TBL] [Abstract][Full Text] [Related]
46. Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line.
Kovacs I; Yamamura HI; Waite SL; Varga EV; Roeske WR
J Pharmacol Exp Ther; 1998 Feb; 284(2):500-7. PubMed ID: 9454790
[TBL] [Abstract][Full Text] [Related]
47. A simple method for estimation of agonist activity at receptor subtypes: comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells.
Ehlert FJ; Griffin MT; Sawyer GW; Bailon R
J Pharmacol Exp Ther; 1999 May; 289(2):981-92. PubMed ID: 10215678
[TBL] [Abstract][Full Text] [Related]
48. Wash-resistantly bound xanomeline inhibits acetylcholine release by persistent activation of presynaptic M(2) and M(4) muscarinic receptors in rat brain.
Machová E; Jakubík J; El-Fakahany EE; Dolezal V
J Pharmacol Exp Ther; 2007 Jul; 322(1):316-23. PubMed ID: 17446301
[TBL] [Abstract][Full Text] [Related]
49. Pharmacological characterization of the novel cholinomimetic L-689,660 at cloned and native brain muscarinic receptors.
Aagaard P; McKinney M
J Pharmacol Exp Ther; 1993 Dec; 267(3):1478-83. PubMed ID: 8263809
[TBL] [Abstract][Full Text] [Related]
50. Differential coupling of muscarinic M1, M2, and M3 receptors to phosphoinositide hydrolysis in urinary bladder and longitudinal muscle of the ileum of the mouse.
Tran JA; Matsui M; Ehlert FJ
J Pharmacol Exp Ther; 2006 Aug; 318(2):649-56. PubMed ID: 16675640
[TBL] [Abstract][Full Text] [Related]
51. Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex.
De Lorme KC; Grant MK; Noetzel MJ; Polson SB; El-Fakahany EE
J Pharmacol Exp Ther; 2007 Dec; 323(3):868-76. PubMed ID: 17855477
[TBL] [Abstract][Full Text] [Related]
52. Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic receptor antagonist.
Cheng K; Khurana S; Chen Y; Kennedy RH; Zimniak P; Raufman JP
J Pharmacol Exp Ther; 2002 Oct; 303(1):29-35. PubMed ID: 12235229
[TBL] [Abstract][Full Text] [Related]
53. The constitutive activity of the human muscarinic M3 receptor unmasks differences in the pharmacology of anticholinergics.
Casarosa P; Kiechle T; Sieger P; Pieper M; Gantner F
J Pharmacol Exp Ther; 2010 Apr; 333(1):201-9. PubMed ID: 20035022
[TBL] [Abstract][Full Text] [Related]
54. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.
Daly JW; Gupta TH; Padgett WL; Pei XF
J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110
[TBL] [Abstract][Full Text] [Related]
55. Enantiomeric N-methyl-4-piperidyl benzilates as muscarinic receptor ligands: Radioligand binding studies and docking studies to models of the three muscarinic receptors M1, M2 and M3.
Selent J; Brandt W; Pamperin D; Göber B
Bioorg Med Chem; 2006 Mar; 14(6):1729-36. PubMed ID: 16290166
[TBL] [Abstract][Full Text] [Related]
56. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland.
Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA
J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916
[TBL] [Abstract][Full Text] [Related]
57. Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5 muscarinic receptors expressed in Chinese Hamster Ovary cells.
Bradley KN; Rowan EG; Harvey AL
Toxicon; 2003 Feb; 41(2):207-15. PubMed ID: 12565740
[TBL] [Abstract][Full Text] [Related]
58. Characterization of methanthelinium binding and function at human M
Irmen M; Holze J; Bödefeld T; Tränkle C
Naunyn Schmiedebergs Arch Pharmacol; 2018 Oct; 391(10):1037-1052. PubMed ID: 29938305
[TBL] [Abstract][Full Text] [Related]
59. Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization.
Schwarz RD; Callahan MJ; Coughenour LL; Dickerson MR; Kinsora JJ; Lipinski WJ; Raby CA; Spencer CJ; Tecle H
J Pharmacol Exp Ther; 1999 Nov; 291(2):812-22. PubMed ID: 10525104
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
